 |
|||||||||||||||
|
|
|||||||||||||||
|
 |
|||
| Spring Meeting Trial Reports: 2011 / 2010 / 2009 | |||
| Genitourinary Newsletter - Summer 2010 | |||
| ID | Study Title | Status | |
| IND.165 | A Randomized Phase II Study of OGX-011 in Combination with Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Patients with Metastatic Hormone Refractory Prostate Cancer MORE... | Permanently Closed | |
| IND.167 | Phase II Study Of BAY 43-9006 (NSC 724772) In Patients With Hormone Refractory Prostate Cancer MORE... | Permanently Closed | |
| IND.195 | A Phase II Study of SB939 in Patients with Recurrent or Metastatic Castration Resistant Prostate Cancer MORE... | Closed | |
| IND.205 | A Phase II Study of PX-866 in Patients With Metastatic Castration Resistant Prostate Cancer (CRPC) MORE... | Open | |
|
BL.7 EORTC 30987 |
Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Cisplatin/Gemcitabine in Patients with Metastatic or Locally Advanced Urothelial Cancer without Prior Systemic Therapy MORE... | Permanently Closed | |
|
BL.8 EORTC 30994 |
Randomized Phase III Trial Comparing Immediate versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4, and/or N+M0 Transitional Cell Carcinoma (TCC) of the Bladder MORE... | Closed | |
|
BL.10 USC 4B951 |
MVAC in Organ-Confined Bladder Cancer Based on p53 Status MORE... | Closed | |
| BL.11 | A Phase III Study of Iressa® in Combination with Intravesical BCG versus Intravesical BCG Alone in High Risk Superficial Transitional Cell Carcinoma of the Bladder MORE... | Permanently Closed | |
| PR.3 | Intergroup (NCIC CTG, CUOG, SWOG, MRC-UK) Phase III Randomized Trial Comparing Total Androgen Blockade versus Total Androgen Blockade Plus Pelvic Irradiation in Clinical Adenocarcinoma of the Prostate MORE... | Permanently Closed | |
| PR.7 | A Phase III Randomized Trial Comparing Intermittent versus Continuous Androgen Suppression for Patients with Prostate-Specific-Antigen Progression in the Clinical Absence of Distant Metastases Following Radiotherapy for Prostate Cancer MORE... | Closed | |
|
PR.8 SWOG 9346 |
Study of Intermittent Androgen Deprivation in Patients with Stage D2 Prostate Cancer, Phase III MORE... | Closed | |
|
PR.9 RTOG P-0011 |
Phase III Clinical Trial for PT3 and/or Margin Positive Prostate Carcinoma Following Radical Prostatectomy (RTOG: P0011) MORE... | Permanently Closed | |
|
PR.10 ACOSOG Z0070 |
Randomized Trial of Radical Prostatectomy versus Brachytherapy for Patients with T1c or T2a N0 M0 Prostate Cancer (ACOSOG: Z0070) MORE... | Permanently Closed | |
|
PR.10C ACOSOG Z0071 |
Health-Related Quality of Life in Patients with Low Risk, Localized Prostate Cancer Randomized to Radical Prostatectomy or Brachytherapy (ACOSOG: Z0071) MORE... | Permanently Closed | |
| PR.11 | A Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer (START) MORE... | Closed | |
| PR.12 | A Phase III Study of Neoadjuvant Docetaxel and Androgen Suppression plus Radiation Therapy versus Androgen Suppression Alone plus Radiation Therapy for High-Risk Localized Adenocarcinoma of the Prostate (DART) MORE... | Permanently Closed | |
|
PR.13 MRC PR10 |
RADICALS: Radiotherapy and Androgen Deprivation In Combination After Local Surgery MORE... | Open | |
|
PRC.2 CALGB 90202 |
A Randomized, Double-Blind, Placebo-Controlled Phase III Study of Early versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men with Prostate Cancer Metastatic to Bone MORE... | Open | |
|
PRC.3 CALGB 90203 |
A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer MORE... | Open | |
| PRP.1 | A Double-Blind, Placebo-Controlled, Randomized Study of Combination Vitamin E, Selenium and Soy Protein Product in Subjects with High Grade Prostatic Intraepithelial Neoplasia MORE... | Permanently Closed | |
| PRP.1B | An Investigation of Molecular and Genetic Risk Factors Associated with Development of Prostate Cancer in Subjects with High Grade Prostatic Intraepithelial Neoplasia Treated with Placebo or Combination Vitamin E, Selenium and Soy Protein Product MORE... | Permanently Closed | |
|
REC.1 CALGB 90206 |
A Phase III Trial of Interferon-Alpha (IFNA) or IFNA Plus Bevacizumab in Advanced Renal Cell Cancer MORE... | Closed | |
|
REC.2 ECOG E2805 |
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma MORE... | Closed | |
| If you have any questions, comments or suggestions, please contact our |